Venous thromboembolism prophylaxis in neurosurgical patients – Statements of Department of Neurosurgery and the Department of Vascular Diseases at the University Medical Centre Ljubljana

Authors

  • Andrej Porčnik Department of Neurosurgery, Division of Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
  • Petra Šinigoj Department of Hypertension, Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
  • Roman Bošnjak Department of Neurosurgery, Division of Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
  • Borut Prestor Department of Neurosurgery, Division of Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
  • Alenka Mavri Department of Vascular Diseases, Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

DOI:

https://doi.org/10.6016/ZdravVestn.3007

Keywords:

venous thromboembolism, neurosurgery, antithrombotics prophylaxis

Abstract

Venous thromboembolism (VTE) is a common and severe complication of neurosurgical operations. The most effective method of VTE prophylaxis is antithrombotic drugs. However, they can increase the risk of bleeding. Moreover, in the case of intracranial or intraspinal haemorrhage, the consequences are often more severe than the benefit of preventing a potential VTE. Neurosurgical operations differ in the risks of VTE and bleeding. Therefore, the most optimal method of VTE prophylaxis should be used for a specific operation. In the article we present an overview of the existing literature and the position statement that has been developed by a working group from the Department of Neurosurgery and the Department of Vascular Diseases at the University Medical Centre Ljubljana.

Downloads

Download data is not yet available.

References

1. Faraoni D, Comes R, Geerts W, Wiles M. ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis. Eur J Anaesthesiol. 2018;35(2):90-5.
DOI: 10.1097/EJA.0000000000000710
PMID: 29112542

2. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e227S-77S.
DOI: 10.1378/chest.11-2297
PMID: 22315263

3. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-458S.
DOI: 10.1378/chest.08-0656
PMID: 18574271

4. Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J Neurosurg. 2011;114(1):40-6.
DOI: 10.3171/2010.8.JNS10332
PMID: 20815694

5. Simanek R, Vormittag R, Hassler M, Roessler K, Schwarz M, Zielinski C, et al. Venous thromboembolism and survival in patients with high-grade glioma. Neuro-oncol. 2007;9(2):89-95.
DOI: 10.1215/15228517-2006-035
PMID: 17327573

6. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332(20):1330-5.
DOI: 10.1056/NEJM199505183322003
PMID: 7715641

7. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3):188S-203S.
DOI: 10.1378/chest.126.3_suppl.188S
PMID: 15383472

8. Dennis M, Sandercock PA, Reid J, Graham C, Murray G, Venables G, et al.; CLOTS Trials Collaboration. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009;373(9679):1958-65.
DOI: 10.1016/S0140-6736(09)60941-7
PMID: 19477503

9. Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Asses. 2005;9(49):iii-iv,ix-x,1-78.
DOI: 10.3310/hta9490
PMID: 16336844

10. Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost. 2005;94(6):1181-5.
DOI: 10.1160/TH05-04-0222
PMID: 16411391

11. Chan AT, Atiemo A, Diran LK, Licholai GP, McLaren Black P, Creager MA, et al. Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis. 1999;8(2):139-42.
DOI: 10.1023/A:1008915202859
PMID: 10436144

12. Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney-Wilensky E, Stein SC. Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery. 2005;56(6):1286-92.
DOI: 10.1227/01.NEU.0000159882.11635.EA
PMID: 15918945

13. Algattas H, Kimmell KT, Vates GE, Jahromi BS. Analysis of Venous Thromboembolism Risk in Patients Undergoing Craniotomy. World Neurosurg. 2015;84(5):1372-9.
DOI: 10.1016/j.wneu.2015.06.033
PMID: 26117085

14. Wong JM, Panchmatia JR, Ziewacz JE, Bader AM, Dunn IF, Laws ER, et al. Patterns in neurosurgical adverse events: intracranial neoplasm surgery. Neurosurg Focus. 2012;33(5):E16.
DOI: 10.3171/2012.7.FOCUS12183
PMID: 23116096

15. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer. 2000;89(3):640-6.
DOI: 10.1002/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E
PMID: 10931464

16. Valladares JB, Hankinson J. Incidence of lower extremity deep vein thrombosis in neurosurgical patients. Neurosurgery. 1980;6(2):138-41.
DOI: 10.1227/00006123-198002000-00004
PMID: 7366805

17. Henwood PC, Kennedy TM, Thomson L, Galanis T, Tzanis GL, Merli GJ, et al. The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis. J Thromb Thrombolysis. 2011;32(2):209-14.
DOI: 10.1007/s11239-011-0583-8
PMID: 21505787

18. Ruff RL, Posner JB. Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol. 1983;13(3):334-6.
DOI: 10.1002/ana.410130320
PMID: 6303201

19. Ganau M, Prisco L, Cebula H, Todeschi J, Abid H, Ligarotti G, et al. Risk of Deep vein thrombosis in neurosurgery: state of the art on prophylaxis protocols and best clinical practices. J Clin Neurosci. 2017;45:60-6.
DOI: 10.1016/j.jocn.2017.08.008
PMID: 28890040

20. Hamilton MG, Yee WH, Hull RD, Ghali WA. Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis. Neurosurgery. 2011;68(3):571-81.
DOI: 10.1227/NEU.0b013e3182093145
PMID: 21311292

21. Collen JF, Jackson JL, Shorr AF, Moores LK. Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest. 2008;134(2):237-49.
DOI: 10.1378/chest.08-0023
PMID: 18641095

22. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med. 2000;160(15):2327-32.
DOI: 10.1001/archinte.160.15.2327
PMID: 10927730

23. Frisius J, Ebeling M, Karst M, Fahlbusch R, Schedel I, Gerganov V, et al. Prevention of venous thromboembolic complications with and without intermittent pneumatic compression in neurosurgical cranial procedures using intraoperative magnetic resonance imaging. A retrospective analysis. Clin Neurol Neurosurg. 2015;133:46-54.
DOI: 10.1016/j.clineuro.2015.03.005
PMID: 25837574

24. Chibbaro S, Cebula H, Todeschi J, Fricia M, Vigouroux D, Abid H, et al. Evolution of Prophylaxis Protocols for Venous Thromboembolism in Neurosurgery: Results from a Prospective Comparative Study on Low-Molecular-Weight Heparin, Elastic Stockings, and Intermittent Pneumatic Compression Devices. World Neurosurg. 2018;109:e510-6.
DOI: 10.1016/j.wneu.2017.10.012
PMID: 29033376

25. Hacker RI, Ritter G, Nelson C, Knobel D, Gupta R, Hopkins K, et al. Subcutaneous heparin does not increase postoperative complications in neurosurgical patients: an institutional experience. J Crit Care. 2012;27(3):250-4.
DOI: 10.1016/j.jcrc.2011.09.005
PMID: 22226424

26. Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery. 1998;43(5):1074-81.
DOI: 10.1097/00006123-199811000-00039
PMID: 9802851

27. Shaikhouni A, Baum J, Lonser RR. Deep Vein Thrombosis Prophylaxis in the Neurosurgical Patient. Neurosurg Clin N Am. 2018;29(4):567-74.
DOI: 10.1016/j.nec.2018.06.010
PMID: 30223969

28. Hansrani V, Khanbhai M, McCollum C. The Prevention of Venous Thromboembolism in Surgical Patient. In: Islam M, ed. Thrombosis and Embolism: from Research to Clinical Practice. Berlin: Springer; 2016.

29. Nyquist P, Jichici D, Bautista C, Burns J, Chhangani S, DeFilippis M, et al. Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Executive Summary of Evidence-Based Guidelines: A Statement for Healthcare Professionals From the Neurocritical Care Society and Society of Critical Care Medicine. Crit Care Med. 2017;45(3):476-9.
DOI: 10.1097/CCM.0000000000002247
PMID: 28085682

30. Schoenfeld AJ, Herzog JP, Dunn JC, Bader JO, Belmont PJ. Patient-based and surgical characteristics associated with the acute development of deep venous thrombosis and pulmonary embolism after spine surgery. Spine. 2013;38(21):1892-8.
DOI: 10.1097/BRS.0b013e31829fc3a0
PMID: 23778367

31. Sansone JM, del Rio AM, Anderson PA. The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery. J Bone Joint Surg Am. 2010;92(2):304-13.
DOI: 10.2106/JBJS.H.01815
PMID: 20124056

32. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446-55.
PMID: 12958614

33. Gephart MG, Zygourakis CC, Arrigo RT, Kalanithi PS, Lad SP, Boakye M. Venous thromboembolism after thoracic/thoracolumbar spinal fusion. World Neurosurg. 2012;78(5):545-52.
DOI: 10.1016/j.wneu.2011.12.089
PMID: 22381270

34. Gerlach R, Raabe A, Beck J, Woszczyk A, Seifert V. Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J. 2004;13(1):9-13.
DOI: 10.1007/s00586-003-0642-8
PMID: 14615928

35. Senders ZJ, Zussman BM, Maltenfort MG, Sharan AD, Ratliff JK, Harrop JS. The incidence of pulmonary embolism (PE) after spinal fusions. Clin Neurol Neurosurg. 2012;114(7):897-901.
DOI: 10.1016/j.clineuro.2012.01.044
PMID: 22386262

36. Cox JB, Weaver KJ, Neal DW, Jacob RP, Hoh DJ. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: clinical article. J Neurosurg Spine. 2014;21(4):677-84.
DOI: 10.3171/2014.6.SPINE13447
PMID: 25105337

37. Strom RG, Frempong-Boadu AK. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism. Spine. 2013;38(23):E1498-502.
DOI: 10.1097/BRS.0b013e3182a4408d
PMID: 23873245

Published

2022-04-30

Issue

Section

Professional Article

How to Cite

1.
Venous thromboembolism prophylaxis in neurosurgical patients – Statements of Department of Neurosurgery and the Department of Vascular Diseases at the University Medical Centre Ljubljana. ZdravVestn [Internet]. 2022 Apr. 30 [cited 2024 Nov. 2];91(3-4):108-16. Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/3007

Most read articles by the same author(s)

1 2 3 > >>